NASDAQ · USD

NEXGEL, Inc. (NXGLW) Análisis de acciones

NEXGEL, Inc. (NXGLW) es una acción que cotiza en NASDAQ en dólar estadounidense.

NXGLW

0,01 $

+0,00 $ (+1.63%)

4 sept 2026 · Cierre de mercado

Este es un instrumento derivado — un warrant sobre las acciones ordinarias de NEXGEL, Inc. (NXGL).

Los fundamentales del emisor se muestran en la página del emisor, no aquí.

Ver NXGL →

Historial de Precios

Pasa el cursor para ver el cierre diario. La línea punteada marca la apertura del periodo.

Estadísticas clave de NXGLW

Datos a 4 sept 2026

Cotización

Apertura: 0,31 $
Cierre anterior: 0,01 $
Rango del día: 0,01–0,02
Rango 52 semanas: 0,01–0,02
Volumen: 8.77K
Beta: 0.75

Solo se muestran las métricas que publica la empresa. Datos proporcionados por Yahoo Finance a través de yfinance. Actualizado diariamente.

Acerca de NEXGEL, Inc.

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

La descripción de la empresa se muestra en inglés.

Visitar sitio web →